Imaging Characteristics and Treatment Outcome Per Patient (n = 14)
| No. of metastases | SUVmean/max | ||||||||
| Tumor location | Functional NET | CT | PET | % | Baseline | 2 wk | 12 wk | Treatment duration (mo) | Best change CT target lesions (%) |
| Pancreas* | — | 82 | 34 | 41 | 10.9 | 10.3 | 6.7 | 21+ | −14 |
| Pancreas† | — | 7 | 0 | 0 | — | — | — | 1 | NA |
| Pancreas | — | 26 | 1 | 4 | 5.5 | 5.6 | 4.8 | 21+ | −7 |
| Pancreas | — | 1 | 0 | 0 | — | — | — | 20+ | 13 |
| Pancreas | — | 39 | 11 | 31 | 5.1 | 4.5 | 3.6 | 10 | −4 |
| Pancreas | — | 27 | 4 | 15 | 2.9 | 2.8 | 2.7 | 14+ | −9 |
| Pancreas | — | 3 | 3 | 100 | 4.8 | 5.9 | 5.7 | 12 | 0 |
| Duodenum | Gastrin | 16 | 3 | 19 | 3.4 | 3.2 | 2.6 | 6 | −5 |
| Lung | Serotonin | 41 | 3 | 7 | 7.0 | 7.9 | 9.1 | 8 | −3 |
| Small bowel† | Serotonin | 2 | 0 | 0 | — | — | — | 3 | 11 |
| Small bowel‡ | Serotonin | 29 | 2 | 7 | 8.5 | 8.8 | 8.8 | 12 | 1 |
| Small bowel | Serotonin | 25 | 0 | 0 | — | — | — | 12 | −19 |
| Unknown | Serotonin | 15 | 1 | 7 | 10.4 | 8.6 | 7.7 | 18+ | −9 |
| Unknown | Serotonin | 14 | 1 | 7 | 8.6 | 4.9 | 2.6 | 16+ | −13 |